Anxiety News and Research

Latest Anxiety News and Research

Fear of the fat promoted to curb obesity

The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body’s internal organs. The AMA’s proposals are part of a submission calling for $63 million to fight obesity.

3 Jan 2011

New women’s health policy inadequate

The Gillard government is being criticized for issuing a women’s health policy without announcing more funding for struggling women’s services. This is the first national women’s health policy in 21 years that claims to ensure women “have access to the right healthcare at the right time”.

30 Dec 2010

Teenage autistic boy allowed sex change procedure

A 16 year old autistic schoolboy has been granted approval to begin treatment for a sex change. He will have the provision to have his sperm frozen in case he decides he wants children. The decision came from Family Court judge Justice Linda Dessau on an emergency application from the boy’s parents so that he can begin therapy before his puberty fully sets in.

30 Dec 2010

New innovative program to identify and treat combat veterans suffering from PTSD

An innovative program to identify and treat combat veterans suffering from Post Traumatic Stress Disorder - but who have not sought treatment - has been started by U.S.VETS, the nation's largest nonprofit devoted to providing housing and other services to homeless and at-risk veterans.

29 Dec 2010

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.

28 Dec 2010

Stress may boost memory: Study

In a new study researchers have found that stress can enhance ordinary, unrelated memories. This may open up new avenues in management of patients of post-traumatic stress disorder (PTSD) and related afflictions say experts.

27 Dec 2010

Transition, Elan to modify collaboration agreement for development, commercialization of ELND005

Transition Therapeutics Inc. today announced that the Company and Elan Corporation, plc have mutually agreed to modify their collaboration agreement for the development and commercialization of ELND005.

27 Dec 2010

Pregnant women veterans face increase risk of mental health problems

Pregnancy among women veterans who served in Iraq and Afghanistan appears to increase their risk for mental health problems such as depression, anxiety, and post-traumatic stress disorder, according to a study published in Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

22 Dec 2010

Clue to the blues that come with the flu

Vanderbilt University researchers may have found a clue to the blues that can come with the flu - depression may be triggered by the same mechanisms that enable the immune system to respond to infection.

21 Dec 2010

'CART' treatment better than traditional cognitive therapy at altering hyperventilation and panic symptoms

A new treatment program teaches people who suffer from panic disorder how to reduce the terrorizing symptoms by normalizing their breathing.

21 Dec 2010

Aeterna Zentaris reaches agreement with FDA for Solorel SPA as a diagnostic test in AGHD

Aeterna Zentaris Inc. today announced that it has reached agreement with the Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for Solorel® (AEZS-130, macimorelin) which will enable the Company to complete the ongoing registration study required to gain approval as a diagnostic test for Adult Growth Hormone Deficiency (AGHD).

20 Dec 2010

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

DiaGenic ASA and Pfizer Inc today signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer's disease (AD) using DiaGenic's patented gene expression technology and its blood samples from ongoing clinical studies.

17 Dec 2010

Research project examines unfamiliar space to make it 'older person-friendly'

Urban planning needs to consider how older people use walking routes as well as public areas, concludes a Research Council UK-funded research project from the New Dynamics of Ageing Programme.

17 Dec 2010

Mayo Clinic ACTS project supports African-American dementia caregivers

With a rapidly expanding population of elders, the number of dementia caregivers in Florida is increasing exponentially. According to the Alzheimer's Association, nearly 10 million caregivers provide unpaid care to people with Alzheimer's disease. Finding the best way to support caregivers, especially with fewer state resources available, is one focus of ongoing research at Mayo Clinic in Florida.

17 Dec 2010

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Researchers at Children's Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls.

16 Dec 2010

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.

16 Dec 2010

Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target

Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.

16 Dec 2010

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.

16 Dec 2010

Phoenix-area Mexican students experience acculturation stress related to discrimination

Perceived ethnic discrimination among Mexican and Mexican American students from Phoenix-area middle schools places them at risk for increased stress when trying to acculturate with mainstream U.S. culture, according to a new study.

16 Dec 2010

Anxious and depressed patients more likely to report worse results after hip replacement

Patients who suffer from anxiety and depression are more likely to report worse results after a hip replacement. A year-long wait for the operation also entails significant costs to both society and the individual, reveals a new thesis from the University of Gothenburg, Sweden.

15 Dec 2010

Anxiety News and Research

Latest Anxiety News and Research

Fear of the fat promoted to curb obesity

New women’s health policy inadequate

Teenage autistic boy allowed sex change procedure

New innovative program to identify and treat combat veterans suffering from PTSD

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Stress may boost memory: Study

Transition, Elan to modify collaboration agreement for development, commercialization of ELND005

Pregnant women veterans face increase risk of mental health problems

Clue to the blues that come with the flu

'CART' treatment better than traditional cognitive therapy at altering hyperventilation and panic symptoms

Aeterna Zentaris reaches agreement with FDA for Solorel SPA as a diagnostic test in AGHD

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

Research project examines unfamiliar space to make it 'older person-friendly'

Mayo Clinic ACTS project supports African-American dementia caregivers

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Phoenix-area Mexican students experience acculturation stress related to discrimination

Anxious and depressed patients more likely to report worse results after hip replacement

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Anxiety News and Research

Latest Anxiety News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in